Lockheed Martin, Rheinmetall Plan First ATACMS Missile Production in Germany 
Telenor to Buy Controlling Stake in Bahnhof in $630 Million Broadband Deal 
Japan Regional Bank Stocks Drop After Zentoshin Bankruptcy Sparks Credit Risk Concerns 
Apple Tests China's CXMT Memory Chips as DRAM Maker Gains Global Market Share 
Zhipu AI Raises HK$31.37 Billion in Discounted Share Sale to Accelerate AI Growth 
Mizuho’s Top U.S. Industrials Stocks: Why Corteva and Stanley Black & Decker Stand Out 
Kitron Q2 Revenue Beats Estimates as Defense Demand Lifts Growth 
Wolfspeed Sues Navitas Over GaN and SiC Patent Infringement 
Oil and LNG Tankers Turn Back as Strait of Hormuz Security Risks Escalate 
Samsung Chairman Lee Jae-yong Expected to Meet Nvidia CEO Jensen Huang on AI and Chip Partnership 
Bernstein Names IAG, Ryanair as Top European Airline Stocks Ahead of Earnings 
Goldman AM Sees Strong Buyout Opportunities in Japan, South Korea and Australia 
Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI 
OpenAI GPT-5.6 Set for Wider Release After U.S. Commerce Approval, Report Says 
Netflix, Disney, YouTube Eye FIFA World Cup TV Rights in Multi-Billion Dollar Battle 
BHP Faces Port Hedland Strike Threat as Iron Ore Export Risks Grow 
CUPERTINO, CA, May 04, 2018 -- Aemetis, Inc. (NASDAQ: AMTX) today announced that Eric McAfee, Chairman and CEO, is scheduled to present on Wednesday, May 9, 2018 at the Disruptive Growth & Healthcare Conference in New York. The conference will be held at the Reed Smith office in New York City.
About Aemetis
Headquartered in Cupertino, California, Aemetis is an advanced renewable fuels and biochemicals company focused on the acquisition, development and commercialization of innovative technologies that replace traditional petroleum-based products by the conversion of ethanol and biodiesel plants into advanced biorefineries. Founded in 2006, Aemetis owns and operates a 60 million gallon per year ethanol production facility in California’s Central Valley, near Modesto. Aemetis also owns and operates a 50 million gallon per year renewable chemical and advanced fuel production facility on the East Coast of India producing high quality distilled biodiesel and refined glycerin for customers in India, the US and Europe. Aemetis operates a research and development laboratory, and holds a portfolio of patents and related technology licenses for the production of renewable fuels and biochemicals. For additional information about Aemetis, please visit www.aemetis.com.
External Investor Relations
Contact:
Kirin Smith
PCG Advisory Group
(646) 863-6519
Company Investor Relations/
Media Contact:
Todd Waltz
(408) 213-0940
